Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-080133

Chief Scientific Officer sold 43,700 shares at $20.09 ($877,933)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reich Kristian Chief Scientific Officer 2026-07-20 Sale 10b5-1 −43,700 $20.09 $877,933 2,764,746 I
Open-market sales · 43,700 sh · avg $20.09 · $877,933
Loading xslF345X06/ownership.xml…